The controlled clinical trial as an instrument to evaluate the efficacy and safety of therapeutic interventions is considered the most reliable method from the clinical and regulatory point of view of medicines and medical products.
education and training
as a hub of Bioinformatics
A research team has studied the efficacy of new CHO/PA polymeric nanoparticles for the sustained delivery of a drug used in breast cancer therapy. Some of the experiments have been carried out in the NCD-SWEET beamline at ALBA.
The Conference "The opportunity for Big Data and Artificial Intelligence in clinical decision-making and health evaluation" held in Barcelona, on November 6th, 2019, was organized by Bioinformatics Barcelona (BIB), the Faculty of Medicine and Health Sciences of the University of Barcelona (UB) and professional societies.